{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:50:10Z","timestamp":1790740210391,"version":"4.1.0"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s15010-021-01640-7","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:03:21Z","timestamp":1623837801000},"page":"1107-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?"],"prefix":"10.1007","volume":"49","author":[{"given":"Vasiliki","family":"Soulountsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Schizodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafeim Chrysovalantis","family":"Kotoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"1","key":"1640_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","volume":"183","author":"AH Limper","year":"2011","unstructured":"Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, et al. An official American thoracic society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):96\u2013128.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1640_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/viru.26187","volume":"5","author":"J Delaloye","year":"2014","unstructured":"Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014;5(1):161\u20139.","journal-title":"Virulence"},{"issue":"3","key":"1640_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/01.CCM.0000201897.78123.44","volume":"34","author":"L Ostrosky-Zeichner","year":"2006","unstructured":"Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34(3):857\u201363.","journal-title":"Crit Care Med"},{"issue":"2","key":"1640_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007;45(2):205\u201316.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1640_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1097\/CCM.0b013e31819da98e","volume":"37","author":"S Blot","year":"2009","unstructured":"Blot S, Cankurtaran M, Petrovic M, Vandijck D, Lizy C, Decruyenaere J, et al. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patients. Crit Care Med. 2009;37(5):1634\u201341.","journal-title":"Crit Care Med"},{"issue":"3","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309\u201317.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1640_CR7","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41(9):1601\u201310.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1640_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","volume":"40","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Righi E, Ansaldi F, Merelli M, Trucchi C, De Pascale G, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839\u201345.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1640_CR9","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","volume":"43","author":"B Almirante","year":"2005","unstructured":"Almirante B, Rodr\u00edguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43(4):1829\u201335.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1640_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jinf.2009.08.020","volume":"59","author":"I Hassan","year":"2009","unstructured":"Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Infect. 2009;59(5):360\u20135.","journal-title":"J Infect"},{"issue":"1","key":"1640_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","volume":"6","author":"O Leroy","year":"2016","unstructured":"Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, et al. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann Intensive Care. 2016;6(1):2.","journal-title":"Ann Intensive Care"},{"issue":"Suppl 2","key":"1640_CR12","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/S0924-8579(08)70006-2","volume":"32","author":"E Bouza","year":"2008","unstructured":"Bouza E, Mu\u00f1oz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents. 2008;32(Suppl 2):S87-91.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"1640_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/502581","volume":"26","author":"J Morgan","year":"2005","unstructured":"Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005;26(6):540\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 1","key":"1640_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2165\/11315500-000000000-00000","volume":"69","author":"E Concia","year":"2009","unstructured":"Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs. 2009;69(Suppl 1):5\u201314.","journal-title":"Drugs"},{"issue":"21","key":"1640_CR15","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323\u20139.","journal-title":"JAMA"},{"issue":"9","key":"1640_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1086\/496922","volume":"41","author":"TE Zaoutis","year":"2005","unstructured":"Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41(9):1232\u20139.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1640_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","volume":"27","author":"AM Tortorano","year":"2006","unstructured":"Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents. 2006;27(5):359\u201366.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"1640_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","volume":"3","author":"P Eggimann","year":"2003","unstructured":"Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3(11):685\u2013702.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1640_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00134-014-3281-0","volume":"40","author":"C Le\u00f3n","year":"2014","unstructured":"Le\u00f3n C, Ostrosky-Zeichner L, Schuster M. What\u2019s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med. 2014;40(6):808\u201319.","journal-title":"Intensive Care Med"},{"issue":"11","key":"1640_CR20","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","volume":"17","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, de Almeida J\u00fanior JN, Slavin MA, Chen SC, Sorrell TC. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17(11):e344\u201356.","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"1640_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445\u201356.","journal-title":"N Engl J Med"},{"issue":"11","key":"1640_CR22","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/cid\/ciw610","volume":"63","author":"EG Playford","year":"2016","unstructured":"Playford EG, Lipman J, Jones M, Lau AF, Kabir M, Chen SC, et al. Problematic dichotomization of risk for intensive care unit (ICU)-acquired invasive candidiasis: results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients. Clin Infect Dis. 2016;63(11):1463\u20139.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"1640_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1439-0507.2008.01570.x","volume":"51","author":"E Hollenbach","year":"2008","unstructured":"Hollenbach E. To treat or not to treat\u2013critically ill patients with candiduria. Mycoses. 2008;51(Suppl 2):12\u201324.","journal-title":"Mycoses"},{"issue":"1","key":"1640_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00134-008-1338-7","volume":"35","author":"BP Guery","year":"2009","unstructured":"Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges S\u00e1 M, Johnson EM, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I Epidemiology and diagnosis. Intensive Care Med. 2009;35(1):55\u201362.","journal-title":"Intensive Care Med"},{"issue":"8","key":"1640_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ofid\/ofy187","volume":"5","author":"BJ Webb","year":"2018","unstructured":"Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J. Epidemiology and clinical features of invasive fungal infection in a US health care network. Open Forum Infect Dis. 2018;5(8):187.","journal-title":"Open Forum Infect Dis"},{"key":"1640_CR26","doi-asserted-by":"publisher","first-page":"7495218","DOI":"10.1155\/2018\/7495218","volume":"2018","author":"MB Marak","year":"2018","unstructured":"Marak MB, Dhanashree B. Antifungal susceptibility and biofilm production of Candida spp. isolated from clinical samples. Int J Microbiol. 2018;2018:7495218.","journal-title":"Int J Microbiol"},{"issue":"6","key":"1640_CR27","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1186\/cc10574","volume":"15","author":"H Muskett","year":"2011","unstructured":"Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care. 2011;15(6):R287.","journal-title":"Crit Care"},{"issue":"1","key":"1640_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/molecules19011085","volume":"19","author":"E Paramythiotou","year":"2014","unstructured":"Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules. 2014;19(1):1085\u2013119.","journal-title":"Molecules"},{"issue":"1","key":"1640_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1378\/chest.129.1.110","volume":"129","author":"E Azoulay","year":"2006","unstructured":"Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest. 2006;129(1):110\u20137.","journal-title":"Chest"},{"issue":"19","key":"1640_CR30","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2165\/00003495-200464190-00002","volume":"64","author":"S Blot","year":"2004","unstructured":"Blot S, Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs. 2004;64(19):2159\u201375.","journal-title":"Drugs"},{"issue":"5","key":"1640_CR31","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"key":"1640_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2110-5820-1-37","volume":"1","author":"P Eggimann","year":"2011","unstructured":"Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1:37.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"1640_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cid\/cit722","volume":"58","author":"M Ouederni","year":"2014","unstructured":"Ouederni M, Sanal O, Ikinciogullari A, Tezcan I, Dogu F, Sologuren I, et al. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor \u03b21 deficiency. Clin Infect Dis. 2014;58(2):204\u201313.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1640_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","volume":"39","author":"DH Kett","year":"2011","unstructured":"Kett DH, Azoulay E, Echeverria PM, Vincent JL. Extended Prevalence of infection in ICU study (EPIC II) group of investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med. 2011;39(4):665\u201370.","journal-title":"Crit Care Med"},{"issue":"1","key":"1640_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","volume":"23","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23(1):219.","journal-title":"Crit Care"},{"issue":"9","key":"1640_CR36","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/cid\/cis200","volume":"54","author":"MH Nguyen","year":"2012","unstructured":"Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, et al. Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis. 2012;54(9):1240\u20138.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1640_CR37","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1093\/jac\/dku225","volume":"69","author":"J Fort\u00fan","year":"2014","unstructured":"Fort\u00fan J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Pem\u00e1n J, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother. 2014;69(11):3134\u201341.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1640_CR38","doi-asserted-by":"publisher","first-page":"e01909","DOI":"10.1128\/JCM.01909-17","volume":"56","author":"CJ Clancy","year":"2018","unstructured":"Clancy CJ, Nguyen MH. Diagnosing invasive Candidiasis. J Clin Microbiol. 2018;56(5):e01909-e1917.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1640_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.diagmicrobio.2007.07.001","volume":"59","author":"SA Klotz","year":"2007","unstructured":"Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis. 2007;59(4):401\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"1640_CR40","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/jac\/dkt099","volume":"68","author":"E Bouza","year":"2013","unstructured":"Bouza E, Burillo A, Mu\u00f1oz P, Guinea J, Mar\u00edn M, Rodr\u00edguez-Cr\u00e9ixems M. Mixed bloodstream infections involving bacteria and Candida spp. J Antimicrob Chemother. 2013;68(8):1881\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"1640_CR41","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/cid\/cit006","volume":"56","author":"CJ Clancy","year":"2013","unstructured":"Clancy CJ, Nguyen MH. Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56(9):1284\u201392.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1640_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1128\/JCM.01602-10","volume":"49","author":"T Avni","year":"2011","unstructured":"Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49(2):665\u201370.","journal-title":"J Clin Microbiol"},{"issue":"13","key":"1640_CR43","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198\u2013208.","journal-title":"N Engl J Med"},{"issue":"3","key":"1640_CR44","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/jac\/dki258","volume":"56","author":"KB Laupland","year":"2005","unstructured":"Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S. Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother. 2005;56(3):532\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"1640_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13054-016-1229-1","volume":"20","author":"JA Paiva","year":"2016","unstructured":"Paiva JA, Pereira JM, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, et al. Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care. 2016;20:53.","journal-title":"Crit Care"},{"issue":"6","key":"1640_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10096-007-0316-2","volume":"26","author":"G Dimopoulos","year":"2007","unstructured":"Dimopoulos G, Karabinis A, Samonis G, Falagas ME. Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis. 2007;26(6):377\u201384.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"16","key":"1640_CR47","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546\u201354.","journal-title":"N Engl J Med"},{"issue":"9","key":"1640_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797\u2013808.","journal-title":"N Engl J Med"},{"issue":"14","key":"1640_CR49","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","volume":"372","author":"PR Mouncey","year":"2015","unstructured":"Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301\u201311.","journal-title":"N Engl J Med"},{"issue":"6","key":"1640_CR50","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975\u201384.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1640_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/380637","volume":"38","author":"O Marchetti","year":"2004","unstructured":"Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000. Clin Infect Dis. 2004;38(3):311\u201320.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1640_CR52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1469-0691.2005.01318.x","volume":"12","author":"H Wisplinghoff","year":"2006","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. Clin Microbiol Infect. 2006;12(2):170\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1640_CR53","first-page":"65","volume":"3","author":"JA Guzman","year":"2011","unstructured":"Guzman JA, Tchokonte R, Sobel JD. Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res. 2011;3(2):65\u201371.","journal-title":"J Clin Med Res"},{"issue":"12","key":"1640_CR54","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/cid\/cis305","volume":"54","author":"M Kollef","year":"2012","unstructured":"Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54(12):1739\u201346.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1640_CR55","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","volume":"37","author":"O Leroy","year":"2009","unstructured":"Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005\u20132006). Crit Care Med. 2009;37(5):1612\u20138.","journal-title":"Crit Care Med"},{"issue":"2","key":"1640_CR56","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/cc12598","volume":"17","author":"JP Quenot","year":"2013","unstructured":"Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, et al. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care. 2013;17(2):R65.","journal-title":"Crit Care"},{"issue":"5","key":"1640_CR57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/21548331.2018.1518104","volume":"46","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Vena A, Russo A. Management of patients with septic shock due to Candida infection. Hosp Pract. 2018;46(5):258\u201365.","journal-title":"Hosp Pract"},{"issue":"12","key":"1640_CR58","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1001\/archinte.1988.00380120094019","volume":"148","author":"SB Wey","year":"1988","unstructured":"Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988;148(12):2642\u20135.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1640_CR59","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1086\/513640","volume":"24","author":"D Pittet","year":"1997","unstructured":"Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis. 1997;24(6):1068\u201378.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1640_CR60","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1086\/514955","volume":"27","author":"AM Rentz","year":"1998","unstructured":"Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis. 1998;27(4):781\u20138.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1640_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1086\/520192","volume":"29","author":"MB Edmond","year":"1999","unstructured":"Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29(2):239\u201344.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1640_CR62","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/376906","volume":"37","author":"PG Pappas","year":"2003","unstructured":"Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37(5):634\u201343.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1640_CR63","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","volume":"74","author":"M Pfaller","year":"2012","unstructured":"Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH Alliance\u00ae) registry, 2004\u20132008. Diagn Microbiol Infect Dis. 2012;74(4):323\u201331.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"1640_CR64","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","volume":"43","author":"O Lortholary","year":"2017","unstructured":"Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F. French mycoses study group. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652\u201362.","journal-title":"Intensive Care Med"},{"issue":"18","key":"1640_CR65","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","volume":"379","author":"SS Magill","year":"2018","unstructured":"Magill SS, O\u2019Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732\u201344.","journal-title":"N Engl J Med"},{"issue":"2","key":"1640_CR66","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/myc.12714","volume":"61","author":"B Goemaere","year":"2018","unstructured":"Goemaere B, Becker P, Van Wijngaerden E, Maertens J, Spriet I, Hendrickx M, et al. Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals. Mycoses. 2018;61(2):127\u201333.","journal-title":"Mycoses"},{"issue":"2","key":"1640_CR67","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/cc10114","volume":"15","author":"JR Prowle","year":"2011","unstructured":"Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15(2):R100.","journal-title":"Crit Care"},{"issue":"3","key":"1640_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10096-008-0618-z","volume":"28","author":"C Le\u00f3n","year":"2009","unstructured":"Le\u00f3n C, Alvarez-Lerma F, Ruiz-Santana S, Le\u00f3n MA, Nolla J, Jord\u00e1 R, et al. Fungal colonization and\/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis. 2009;28(3):233\u201342.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1640_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","volume":"38","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008\u20132009). Int J Antimicrob Agents. 2011;38(1):65\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"1640_CR70","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","volume":"40","author":"O Lortholary","year":"2014","unstructured":"Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002\u20132010). Intensive Care Med. 2014;40(9):1303\u201312.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1640_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jinf.2017.03.011","volume":"75","author":"O Baldesi","year":"2017","unstructured":"Baldesi O, Bailly S, Ruckly S, Lepape A, L\u2019Heriteau F, Aupee M, et al. ICU-acquired candidaemia in France: epidemiology and temporal trends, 2004\u20132013\u2014a study from the REA-RAISIN network. J Infect. 2017;75(1):59\u201367.","journal-title":"J Infect"},{"issue":"1","key":"1640_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","volume":"55","author":"AM Tortorano","year":"2012","unstructured":"Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V, et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006\u20132008). Mycoses. 2012;55(1):73\u20139.","journal-title":"Mycoses"},{"issue":"12","key":"1640_CR73","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","volume":"39","author":"M Bassetti","year":"2013","unstructured":"Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, et al. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39(12):2092\u2013106.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1640_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","volume":"20","author":"J Guinea","year":"2014","unstructured":"Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(6):5\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"24","key":"1640_CR75","doi-asserted-by":"publisher","first-page":"20505","DOI":"10.2807\/ese.18.24.20505-en","volume":"18","author":"E Meyer","year":"2013","unstructured":"Meyer E, Geffers C, Gastmeier P, Schwab F. No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011. Euro Surveill. 2013;18(24):20505.","journal-title":"Euro Surveill"},{"issue":"12","key":"1640_CR76","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1007\/s00134-013-3057-y","volume":"39","author":"L Vogiatzi","year":"2013","unstructured":"Vogiatzi L, Ilia S, Sideri G, Vagelakoudi E, Vassilopoulou M, Sdougka M, et al. Invasive candidiasis in pediatric intensive care in Greece: a nationwide study. Intensive Care Med. 2013;39(12):2188\u201395.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1640_CR77","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s15010-013-0432-0","volume":"41","author":"MT Montagna","year":"2013","unstructured":"Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, Cuna T, et al. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection. 2013;41(3):645\u201353.","journal-title":"Infection"},{"issue":"2","key":"1640_CR78","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","volume":"41","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41(2):285\u201395.","journal-title":"Intensive Care Med"},{"key":"1640_CR79","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s13104-015-1458-4","volume":"8","author":"G Aguilar","year":"2015","unstructured":"Aguilar G, Delgado C, Corrales I, Izquierdo A, Gracia E, Moreno T, et al. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study. BMC Res Notes. 2015;8:491.","journal-title":"BMC Res Notes"},{"issue":"1","key":"1640_CR80","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13613-019-0539-2","volume":"9","author":"E Ghrenassia","year":"2019","unstructured":"Ghrenassia E, Mokart D, Mayaux J, Demoule A, Rezine I, Kerhuel L, et al. Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study. Ann Intensive Care. 2019;9(1):62.","journal-title":"Ann Intensive Care"},{"key":"1640_CR81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2334-6-21","volume":"6","author":"M Bassetti","year":"2006","unstructured":"Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006;6:21.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1640_CR82","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1086\/342300","volume":"35","author":"WE Trick","year":"2002","unstructured":"Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. National nosocomial infections surveillance system hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989\u20131999. Clin Infect Dis. 2002;35(5):627\u201330.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1640_CR83","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/109629603322761409","volume":"4","author":"SM Swoboda","year":"2003","unstructured":"Swoboda SM, Merz WG, Lipsetta PA. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit. Surg Infect. 2003;4(4):345\u201354.","journal-title":"Surg Infect"},{"issue":"2","key":"1640_CR84","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1213\/ane.0b013e3181607262","volume":"106","author":"G Dimopoulos","year":"2008","unstructured":"Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg. 2008;106(2):523\u20139.","journal-title":"Anesth Analg"},{"issue":"2","key":"1640_CR85","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00134-007-0865-y","volume":"34","author":"ME Bougnoux","year":"2008","unstructured":"Bougnoux ME, Kac G, Aegerter P, d\u2019Enfert C, Fagon JY, CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008;34(2):292\u20139.","journal-title":"Intensive Care Med"},{"issue":"7","key":"1640_CR86","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1097\/CCM.0b013e3181760f42","volume":"36","author":"EG Playford","year":"2008","unstructured":"Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med. 2008;36(7):2034\u20139.","journal-title":"Crit Care Med"},{"issue":"3","key":"1640_CR87","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1469-0691.2008.02653.x","volume":"15","author":"KZ Vardakas","year":"2009","unstructured":"Vardakas KZ, Michalopoulos A, Kiriakidou KG, Siampli EP, Samonis G, Falagas ME. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect. 2009;15(3):289\u201392.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1640_CR88","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1439-0507.2009.01787.x","volume":"54","author":"M Pratikaki","year":"2011","unstructured":"Pratikaki M, Platsouka E, Sotiropoulou C, Douka E, Paramythiotou E, Kaltsas P, et al. Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit. Mycoses. 2011;54(2):154\u201361.","journal-title":"Mycoses"},{"issue":"4","key":"1640_CR89","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","volume":"23","author":"AM Tortorano","year":"2004","unstructured":"Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, et al. Epidemiology of candidaemia in Europe: results of 28-month European confederation of medical mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis. 2004;23(4):317\u201322.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1640_CR90","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","volume":"42","author":"RA Hajjeh","year":"2004","unstructured":"Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42(4):1519\u201327.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1640_CR91","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1439-0507.2005.01134.x","volume":"48","author":"TW Boo","year":"2005","unstructured":"Boo TW, O\u2019reilly B, O\u2019leary J, Cryan B. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors. Mycoses. 2005;48(4):251\u20139.","journal-title":"Mycoses"},{"issue":"8","key":"1640_CR92","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1128\/JCM.00773-06","volume":"44","author":"AL Colombo","year":"2006","unstructured":"Colombo AL, Nucci M, Park BJ, Nou\u00e9r SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816\u201323.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1640_CR93","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3201\/eid1210.060389","volume":"12","author":"S Chen","year":"2006","unstructured":"Chen S, Slavin M, Nguyen Q, Marriott D, Playford EG, Ellis D, et al. Active surveillance for candidemia Australia. Emerg Infect Dis. 2006;12(10):1508\u201316.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"1640_CR94","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10096-007-0339-8","volume":"26","author":"K Lagrou","year":"2007","unstructured":"Lagrou K, Verhaegen J, Peetermans WE, De Rijdt T, Maertens J, Van Wijngaerden E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis. 2007;26(8):541\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"1640_CR95","doi-asserted-by":"publisher","first-page":"e24198","DOI":"10.1371\/journal.pone.0024198","volume":"6","author":"M Bassetti","year":"2011","unstructured":"Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE. 2011;6(9):e24198.","journal-title":"PLoS ONE"},{"issue":"5","key":"1640_CR96","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/jac\/dks019","volume":"67","author":"J Pem\u00e1n","year":"2012","unstructured":"Pem\u00e1n J, Cant\u00f3n E, Quind\u00f3s G, Eraso E, Alcoba J, Guinea J, et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother. 2012;67(5):1181\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"1640_CR97","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","volume":"40","author":"AL Colombo","year":"2014","unstructured":"Colombo AL, Guimar\u00e3es T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med. 2014;40(10):1489\u201398.","journal-title":"Intensive Care Med"},{"key":"1640_CR98","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2016.00915","volume":"7","author":"R Rajendran","year":"2016","unstructured":"Rajendran R, Sherry L, Deshpande A, Johnson EM, Hanson MF, Williams C, et al. A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol. 2016;7:915.","journal-title":"Front Microbiol"},{"issue":"2","key":"1640_CR99","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s15010-015-0845-z","volume":"44","author":"F Barchiesi","year":"2016","unstructured":"Barchiesi F, Orsetti E, Gesuita R, Skrami E, Manso E, Candidemia Study Group. Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014. Infection. 2016;44(2):205\u201313.","journal-title":"Infection"},{"issue":"2","key":"1640_CR100","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s15010-018-1217-2","volume":"47","author":"M Papadimitriou-Olivgeris","year":"2019","unstructured":"Papadimitriou-Olivgeris M, Spiliopoulou A, Kolonitsiou F, Bartzavali C, Lambropoulou A, Xaplanteri P, et al. Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009\u20132017) in a university Greek hospital. Infection. 2019;47(2):209\u201316.","journal-title":"Infection"},{"issue":"7","key":"1640_CR101","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/cid\/ciz1061","volume":"71","author":"AY Zhang","year":"2020","unstructured":"Zhang AY, Shrum S, Williams S, Petnic S, Nadle J, Johnston H, et al. The changing epidemiology of candidemia in the United States: injection drug use as an increasingly common risk factor-active surveillance in selected sites, United States, 2014\u20132017. Clin Infect Dis. 2020;71(7):1732\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1640_CR102","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1128\/JCM.40.9.3489-3492.2002","volume":"40","author":"LR Asmundsd\u00f3ttir","year":"2002","unstructured":"Asmundsd\u00f3ttir LR, Erlendsd\u00f3ttir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol. 2002;40(9):3489\u201392.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1640_CR103","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","volume":"40","author":"DJ Diekema","year":"2002","unstructured":"Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40(4):1298\u2013302.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1640_CR104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0195-6701(03)00085-9","volume":"54","author":"C Kibbler","year":"2003","unstructured":"Kibbler C, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect. 2003;54(1):18\u201324.","journal-title":"J Hosp Infect"},{"issue":"8","key":"1640_CR105","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3201\/eid0908.030069","volume":"9","author":"E Poikonen","year":"2003","unstructured":"Poikonen E, Lyytik\u00e4inen O, Anttila VJ, Ruutu P. Candidemia in Finland, 1995\u20131999. Emerg Infect Dis. 2003;9(8):985\u201390.","journal-title":"Emerg Infect Dis"},{"issue":"3B","key":"1640_CR106","doi-asserted-by":"publisher","first-page":"86S","DOI":"10.1016\/0002-9343(91)90349-3","volume":"91","author":"SN Banerjee","year":"1991","unstructured":"Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989. National nosocomial infections surveillance system. Am J Med. 1991;91(3B):86S-89S.","journal-title":"Am J Med"},{"issue":"10","key":"1640_CR107","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/591033","volume":"29","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemia-related hospitalization in the United States, 2000\u20132005. Infect Control Hosp Epidemiol. 2008;29(10):978\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"20","key":"1640_CR108","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1002\/cncr.24507","volume":"115","author":"NV Sipsas","year":"2009","unstructured":"Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009;115(20):4745\u201352.","journal-title":"Cancer"},{"issue":"9","key":"1640_CR109","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1086\/671724","volume":"34","author":"RP Fagan","year":"2013","unstructured":"Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990\u20132010. Infect Control Hosp Epidemiol. 2013;34(9):893\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"1640_CR110","doi-asserted-by":"publisher","first-page":"E343","DOI":"10.1111\/1469-0691.12212","volume":"19","author":"MC Arendrup","year":"2013","unstructured":"Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect. 2013;19(8):E343\u201353.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1640_CR111","doi-asserted-by":"publisher","first-page":"e0120452","DOI":"10.1371\/journal.pone.0120452","volume":"10","author":"AA Cleveland","year":"2015","unstructured":"Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, et al. Declining incidence of candidemia and the shifting epidemiology of candida resistance in two US metropolitan areas, 2008\u20132013: results from population-based surveillance. PLoS ONE. 2015;10(3):e0120452.","journal-title":"PLoS ONE"},{"issue":"1","key":"1640_CR112","doi-asserted-by":"publisher","first-page":"O50","DOI":"10.1111\/1469-0691.12312","volume":"20","author":"MN Gamaletsou","year":"2014","unstructured":"Gamaletsou MN, Walsh TJ, Zaoutis T, Pagoni M, Kotsopoulou M, Voulgarelis M, et al. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Clin Microbiol Infect. 2014;20(1):O50\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1640_CR113","doi-asserted-by":"publisher","first-page":"e0165346","DOI":"10.1371\/journal.pone.0165346","volume":"11","author":"M Ishikane","year":"2016","unstructured":"Ishikane M, Hayakawa K, Kutsuna S, Takeshita N, Ohmagari N. Epidemiology of blood stream infection due to candida species in a tertiary care hospital in Japan over 12 years: importance of peripheral line-associated candidemia. PLoS ONE. 2016;11(10):e0165346.","journal-title":"PLoS ONE"},{"issue":"4","key":"1640_CR114","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1-50.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1640_CR115","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366\u201377.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1640_CR116","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/mmy\/myv060","volume":"53","author":"X Ding","year":"2015","unstructured":"Ding X, Yan D, Sun W, Zeng Z, Su R, Su J. Epidemiology and risk factors for nosocomial non-candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med Mycol. 2015;53(7):684\u201390.","journal-title":"Med Mycol"},{"issue":"1","key":"1640_CR117","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","volume":"73","author":"F Lamoth","year":"2018","unstructured":"Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73(1):i4\u201313.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1640_CR118","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","volume":"36","author":"C Trouv\u00e9","year":"2017","unstructured":"Trouv\u00e9 C, Blot S, Hayette MP, Jonckheere S, Patteet S, Rodriguez-Villalobos H, et al. Epidemiology and reporting of candidaemia in Belgium: a multi-centre study. Eur J Clin Microbiol Infect Dis. 2017;36(4):649\u201355.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1640_CR119","doi-asserted-by":"publisher","first-page":"e0146909","DOI":"10.1371\/journal.pone.0146909","volume":"11","author":"AM Doi","year":"2016","unstructured":"Doi AM, Pignatari AC, Edmond MB, Marra AR, Camargo LF, Siqueira RA, et al. Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program. PLoS ONE. 2016;11(1):e0146909.","journal-title":"PLoS ONE"},{"issue":"3","key":"1640_CR120","doi-asserted-by":"publisher","first-page":"e59373","DOI":"10.1371\/journal.pone.0059373","volume":"8","author":"M Nucci","year":"2013","unstructured":"Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS ONE. 2013;8(3):e59373.","journal-title":"PLoS ONE"},{"issue":"11","key":"1640_CR121","doi-asserted-by":"publisher","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","volume":"14","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14(11):e954\u201366.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"1640_CR122","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhin.2010.09.026","volume":"77","author":"M Ortega","year":"2011","unstructured":"Ortega M, Marco F, Soriano A, Almela M, Mart\u00ednez JA, L\u00f3pez J, et al. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect. 2011;77(2):157\u201361.","journal-title":"J Hosp Infect"},{"issue":"10","key":"1640_CR123","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/myc.12209","volume":"57","author":"E Kazak","year":"2014","unstructured":"Kazak E, Ak\u0131n H, Ener B, S\u0131\u011f\u0131rl\u0131 D, \u00d6zkan \u00d6, G\u00fcrc\u00fco\u011flu E, et al. An investigation of Candida species isolated from blood cultures during 17 years in a university hospital. Mycoses. 2014;57(10):623\u20139.","journal-title":"Mycoses"},{"issue":"3","key":"1640_CR124","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1155\/2013\/929717","volume":"24","author":"GN Al-Rawahi","year":"2013","unstructured":"Al-Rawahi GN, Roscoe DL. Ten-year review of candidemia in a Canadian tertiary care centre: predominance of non-albicans Candida species. Can J Infect Dis Med Microbiol. 2013;24(3):e65\u20138.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"1640_CR125","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2012.02.001","volume":"73","author":"D Diekema","year":"2012","unstructured":"Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012;73(1):45\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"1640_CR126","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","volume":"14","author":"MC Arendrup","year":"2008","unstructured":"Arendrup MC, Fuursted K, Gahrn-Hansen B, Sch\u00f8nheyder HC, Knudsen JD, Jensen IM, et al. Semi-national surveillance of fungaemia in Denmark 2004\u20132006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect. 2008;14(5):487\u201394.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1640_CR127","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/13693786.2012.686673","volume":"51","author":"L Parmeland","year":"2013","unstructured":"Parmeland L, Gazon M, Guerin C, Argaud L, Lehot JJ, Bastien O, et al. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol. 2013;51(1):33\u20137.","journal-title":"Med Mycol"},{"issue":"9","key":"1640_CR128","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1128\/JCM.00179-11","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011;49(9):3300\u20138.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1640_CR129","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","volume":"56","author":"GN Forrest","year":"2008","unstructured":"Forrest GN, Weekes E, Johnson JK. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect. 2008;56(2):126\u20139.","journal-title":"J Infect"},{"issue":"2","key":"1640_CR130","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1128\/AAC.01128-10","volume":"55","author":"O Lortholary","year":"2011","unstructured":"Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F, French Mycosis Study Group. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother. 2011;55(2):532\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1640_CR131","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jac\/dkp251","volume":"64","author":"Bassetti","year":"2009","unstructured":"Bassetti, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, et al. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother. 2009;64(3):625\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1640_CR132","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1128\/AAC.00690-11","volume":"55","author":"E Blanchard","year":"2011","unstructured":"Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D. Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris France. Antimicrob Agents Chemother. 2011;55(11):5358\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1640_CR133","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02873597","volume":"46","author":"D Trubenov\u00e1","year":"2001","unstructured":"Trubenov\u00e1 D, Vir\u00e1gov\u00e1 S, Pilipcinec E, Danko J, Svick\u00fd E, Tk\u00e1cikov\u00e1 L. Candidaemia in cancer patients and in children in a neonatal intensive care unit. Folia Microbiol. 2001;46(2):161\u20134.","journal-title":"Folia Microbiol"},{"issue":"8","key":"1640_CR134","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1099\/0022-1317-51-8-677","volume":"51","author":"I D\u00f3czi","year":"2002","unstructured":"D\u00f3czi I, D\u00f3sa E, Hajd\u00fa E, Nagy E. Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J Med Microbiol. 2002;51(8):677\u201381.","journal-title":"J Med Microbiol"},{"issue":"1","key":"1640_CR135","first-page":"42","volume":"20","author":"R Rani","year":"2002","unstructured":"Rani R, Mohapatra NP, Mehta G, Randhawa VS. Changing trends of Candida species in neonatal septicaemia in a tertiary North Indian hospital. Indian J Med Microbiol. 2002;20(1):42\u20134.","journal-title":"Indian J Med Microbiol"},{"issue":"10","key":"1640_CR136","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10096-004-1210-9","volume":"23","author":"E Roilides","year":"2004","unstructured":"Roilides E, Farmaki E, Evdoridou J, Dotis J, Hatziioannidis E, Tsivitanidou M, et al. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis. 2004;23(10):745\u201350.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"1640_CR137","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.inf.0000168751.11375.d6","volume":"24","author":"SS Shetty","year":"2005","unstructured":"Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998\u20132000. Pediatr Infect Dis J. 2005;24(7):601\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"1640_CR138","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1439-0507.2004.00993.x","volume":"47","author":"GE Giusiano","year":"2004","unstructured":"Giusiano GE, Mangiaterra M, Rojas F, G\u00f3mez V. Yeasts species distribution in neonatal intensive care units in northeast Argentina. Mycoses. 2004;47(7):300\u20133.","journal-title":"Mycoses"},{"issue":"3","key":"1640_CR139","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/01.inf.0000202127.43695.06","volume":"25","author":"D Rodriguez","year":"2006","unstructured":"Rodriguez D, Almirante B, Park BJ, Cuenca-Estrella M, Planes AM, Sanchez F, et al. Candidemia in neonatal intensive care units: Barcelona. Spain Pediatr Infect Dis J. 2006;25(3):224\u20139.","journal-title":"Spain Pediatr Infect Dis J"},{"issue":"1","key":"1640_CR140","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1439-0507.2006.01309.x","volume":"50","author":"F Comert","year":"2007","unstructured":"Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Mycoses. 2007;50(1):52\u20137.","journal-title":"Mycoses"},{"issue":"5","key":"1640_CR141","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10096-007-0448-4","volume":"27","author":"S Costa-de-Oliveira","year":"2008","unstructured":"Costa-de-Oliveira S, Pina-Vaz C, Mendon\u00e7a D, Gon\u00e7alves RA. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis. 2008;27(5):365\u201374.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"1640_CR142","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1542\/peds.2005-1996","volume":"117","author":"SK Fridkin","year":"2006","unstructured":"Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995\u20132004. Pediatrics. 2006;117(5):1680\u20137.","journal-title":"Pediatrics"},{"issue":"8","key":"1640_CR143","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1086\/529435","volume":"46","author":"JK Chow","year":"2008","unstructured":"Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008;46(8):1206\u201313.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1640_CR144","doi-asserted-by":"publisher","first-page":"554.e1","DOI":"10.1016\/j.ijantimicag.2008.10.035","volume":"33","author":"A Holley","year":"2009","unstructured":"Holley A, Dulhunty J, Blot S, Lipman J, Lobo S, Dancer C, et al. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int J Antimicrob Agents. 2009;33(6):554.e1-7.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1640_CR145","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2014.05.021","volume":"81","author":"MC Nieto","year":"2015","unstructured":"Nieto MC, Teller\u00eda O, Cisterna R. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility. Diagn Microbiol Infect Dis. 2015;81(1):34\u201340.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1640_CR146","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/IDR.S80677","volume":"8","author":"R Hirano","year":"2015","unstructured":"Hirano R, Sakamoto Y, Kudo K, Ohnishi M. Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience. Infect Drug Resist. 2015;8:199\u2013205.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"1640_CR147","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/infdis\/167.5.1247","volume":"167","author":"C Beck-Sagu\u00e9","year":"1993","unstructured":"Beck-Sagu\u00e9 C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980\u20131990. National nosocomial infections surveillance system. J Infect Dis. 1993;167(5):1247\u201351.","journal-title":"J Infect Dis"},{"issue":"7","key":"1640_CR148","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(7):19\u201337.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1640_CR149","doi-asserted-by":"publisher","first-page":"e1003079","DOI":"10.1371\/journal.ppat.1003079","volume":"9","author":"MS Lionakis","year":"2013","unstructured":"Lionakis MS, Netea MG. Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog. 2013;9(1):e1003079.","journal-title":"PLoS Pathog"},{"issue":"4","key":"1640_CR150","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1469-0691.2008.01978.x","volume":"14","author":"M Richardson","year":"2008","unstructured":"Richardson M, Lass-Fl\u00f6rl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect. 2008;14(4):5\u201324.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"1640_CR151","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1086\/599039","volume":"48","author":"DL Horn","year":"2009","unstructured":"Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695\u2013703.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1640_CR152","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/myc.12206","volume":"57","author":"MA Pfaller","year":"2014","unstructured":"Pfaller MA, Jones RN, Castanheira M. Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006\u20132011. Mycoses. 2014;57(10):602\u201311.","journal-title":"Mycoses"},{"issue":"3","key":"1640_CR153","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","volume":"52","author":"C Lass-Fl\u00f6rl","year":"2009","unstructured":"Lass-Fl\u00f6rl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses. 2009;52(3):197\u2013205.","journal-title":"Mycoses"},{"issue":"1","key":"1640_CR154","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133\u201363.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1640_CR155","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72(4):1103\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1640_CR156","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11):3435\u201342.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1640_CR157","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1128\/AAC.02155-13","volume":"58","author":"J Guinea","year":"2014","unstructured":"Guinea J, Zaragoza \u00d3, Escribano P, Mart\u00edn-Mazuelos E, Pem\u00e1n J, S\u00e1nchez-Reus F, et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother. 2014;58(3):1529\u201337.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1640_CR158","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"BD Alexander","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD, Jim\u00e9nez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56(12):1724\u201332.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1640_CR159","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/JCM.01811-10","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011;49(1):325\u201334.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1640_CR160","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","volume":"21","author":"L Hesstvedt","year":"2015","unstructured":"Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect. 2015;21(10):938\u201345.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1640_CR161","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/13693786.2012.708107","volume":"51","author":"ML Moretti","year":"2013","unstructured":"Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, et al. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol. 2013;51(3):225\u201330.","journal-title":"Med Mycol"},{"issue":"7","key":"1640_CR162","doi-asserted-by":"publisher","first-page":"e101510","DOI":"10.1371\/journal.pone.0101510","volume":"9","author":"MA Pfaller","year":"2014","unstructured":"Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) registry 2004\u20132008. PLoS ONE. 2014;9(7):e101510.","journal-title":"PLoS ONE"},{"issue":"10","key":"1640_CR163","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1128\/JCM.00946-09","volume":"47","author":"MA Pfaller","year":"2009","unstructured":"Pfaller MA, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, et al. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clin Microbiol. 2009;47(10):3185\u201390.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1640_CR164","doi-asserted-by":"publisher","first-page":"R98","DOI":"10.1186\/cc9033","volume":"14","author":"O Leroy","year":"2010","unstructured":"Leroy O, Mira JP, Montravers P, Gangneux JP, Lortholary O, AmarCand Study Group. Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care. 2010;14(3):R98.","journal-title":"Crit Care"},{"key":"1640_CR165","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","volume":"109","author":"S Nami","year":"2019","unstructured":"Nami S, Mohammadi R, Vakili M, Khezripour K, Mirzaei H, Morovati H. Fungal vaccines, mechanism of actions and immunology: a comprehensive review. Biomed Pharmacother. 2019;109:333\u201344.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1640_CR166","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1590\/0074-02760150335","volume":"110","author":"NP Medici","year":"2015","unstructured":"Medici NP, Del Poeta M. New insights on the development of fungal vaccines: from immunity to recent challenges. Mem Inst Oswaldo Cruz. 2015;110(8):966\u201373.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"1640_CR167","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s15010-002-2131-0","volume":"30","author":"M Arendrup","year":"2002","unstructured":"Arendrup M, Horn T, Frimodt-M\u00f8ller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection. 2002;30(5):286\u201391.","journal-title":"Infection"},{"issue":"8","key":"1640_CR168","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/cis021","volume":"54","author":"DR Andes","year":"2012","unstructured":"Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110\u201322.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1640_CR169","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/jac\/dkx034","volume":"72","author":"SM Rudramurthy","year":"2017","unstructured":"Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72(6):1794\u2013801.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1640_CR170","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","volume":"94","author":"A Chowdhary","year":"2016","unstructured":"Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: new kid on the block in hospital-associated infections? J Hosp Infect. 2016;94(3):209\u201312.","journal-title":"J Hosp Infect"},{"key":"1640_CR171","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","volume":"6","author":"A Cortegiani","year":"2018","unstructured":"Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6:69.","journal-title":"J Intensive Care"},{"issue":"5","key":"1640_CR172","doi-asserted-by":"publisher","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","volume":"13","author":"A Chowdhary","year":"2017","unstructured":"Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5):e1006290.","journal-title":"PLoS Pathog"},{"issue":"2","key":"1640_CR173","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/myc.12439","volume":"59","author":"A Mane","year":"2016","unstructured":"Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, et al. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mycoses. 2016;59(2):93\u2013100.","journal-title":"Mycoses"},{"issue":"13","key":"1640_CR174","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clinmicnews.2017.06.003","volume":"39","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: not your grandfather\u2019s Candida species. Clin Microbiol Newsl. 2017;39(13):99\u2013103.","journal-title":"Clin Microbiol Newsl"},{"issue":"13","key":"1640_CR175","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2807\/1560-7917.ES.2018.23.13.18-00136","volume":"23","author":"A Kohlenberg","year":"2018","unstructured":"Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D, The Candida Auris Survey Collaborative Group. Candida auris: epidemiological situation, laboratory capacity and preparedness in European union and European economic area countries, 2013 to 2017. Euro Surveill. 2018;23(13):18\u201300136.","journal-title":"Euro Surveill"},{"issue":"10","key":"1640_CR176","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3201\/eid1910.130393","volume":"19","author":"A Chowdhary","year":"2013","unstructured":"Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi India. Emerg Infect Dis. 2013;19(10):1670\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"1640_CR177","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","volume":"33","author":"A Chowdhary","year":"2014","unstructured":"Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33(6):919\u201326.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1640_CR178","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jinf.2016.07.008","volume":"73","author":"B Calvo","year":"2016","unstructured":"Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369\u201374.","journal-title":"J Infect"},{"key":"1640_CR179","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","volume":"5","author":"S Schelenz","year":"2016","unstructured":"Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"1640_CR180","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s15010-009-8249-6","volume":"37","author":"J de Ruiter","year":"2009","unstructured":"de Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PH. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009;37(6):522\u20137.","journal-title":"Infection"},{"issue":"1","key":"1640_CR181","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10096-016-2775-9","volume":"36","author":"L Lagunes","year":"2017","unstructured":"Lagunes L, Rey-P\u00e9rez A, Mart\u00edn-G\u00f3mez MT, Vena A, de Egea V, Mu\u00f1oz P, et al. Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain. Eur J Clin Microbiol Infect Dis. 2017;36(1):95\u2013104.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1640_CR182","doi-asserted-by":"publisher","first-page":"0153247","DOI":"10.1371\/journal.pone.0153247","volume":"11","author":"P Vergidis","year":"2016","unstructured":"Vergidis P, Clancy CJ, Shields RK, Park SY, Wildfeuer BN, Simmons RL, et al. Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS ONE. 2016;11(4):0153247.","journal-title":"PLoS ONE"},{"issue":"5","key":"1640_CR183","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;48(5):503\u201335.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1640_CR184","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/01.qco.0000433309.21148.f7","volume":"26","author":"M Rebolledo","year":"2013","unstructured":"Rebolledo M, Sarria JC. Intra-abdominal fungal infections. Curr Opin Infect Dis. 2013;26(5):441\u20136.","journal-title":"Curr Opin Infect Dis"},{"key":"1640_CR185","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-4939-6515-1_18","volume":"1508","author":"FN Zervou","year":"2017","unstructured":"Zervou FN, Zacharioudakis IM, Kurpewski J, Mylonakis E. T2 magnetic resonance for fungal diagnosis. Methods Mol Biol. 2017;1508:305\u201319.","journal-title":"Methods Mol Biol"},{"issue":"9","key":"1640_CR186","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1128\/JCM.00801-14","volume":"52","author":"A Bacconi","year":"2014","unstructured":"Bacconi A, Richmond GS, Baroldi MA, Laffler TG, Blyn LB, Carolan HE, et al. Improved sensitivity for molecular detection of bacterial and Candida infections in blood. J Clin Microbiol. 2014;52(9):3164\u201374.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1640_CR187","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1128\/JCM.02882-12","volume":"51","author":"A Fern\u00e1ndez-Cruz","year":"2013","unstructured":"Fern\u00e1ndez-Cruz A, Mar\u00edn M, Kestler M, Alcal\u00e1 L, Rodriguez-Cr\u00e9ixems M, Bouza E. The value of combining blood culture and SeptiFast data for predicting complicated bloodstream infections caused by gram-positive bacteria or Candida species. J Clin Microbiol. 2013;51(4):1130\u20136.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1640_CR188","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1128\/JCM.00147-10","volume":"48","author":"F Lamoth","year":"2010","unstructured":"Lamoth F, Jaton K, Prod\u2019hom G, Senn L, Bille J, Calandra T, et al. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol. 2010;48(10):3510\u20136.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1640_CR189","doi-asserted-by":"publisher","first-page":"e0158186","DOI":"10.1371\/journal.pone.0158186","volume":"11","author":"D Metzgar","year":"2016","unstructured":"Metzgar D, Frinder MW, Rothman RE, Peterson S, Carroll KC, Zhang SX, et al. The IRIDICA BAC BSI assay: rapid, sensitive and culture-independent identification of bacteria and Candida in blood. PLoS ONE. 2016;11(7):e0158186.","journal-title":"PLoS ONE"},{"issue":"3","key":"1640_CR190","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00003246-200203000-00008","volume":"30","author":"P Sandven","year":"2002","unstructured":"Sandven P, Qvist H, Skovlund E, Giercksky KE, NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002;30(3):541\u20137.","journal-title":"Crit Care Med"},{"issue":"1","key":"1640_CR191","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0732-8893(02)00419-4","volume":"44","author":"SC Lee","year":"2002","unstructured":"Lee SC, Fung CP, Chen HY, Li CT, Jwo SC, Hung YB, et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis. 2002;44(1):23\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"1640_CR192","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/archsurg.137.12.1341","volume":"137","author":"H Dupont","year":"2002","unstructured":"Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP, et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg. 2002;137(12):1341\u20136.","journal-title":"Arch Surg"},{"issue":"12","key":"1640_CR193","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1128\/AAC.04134-14","volume":"58","author":"RK Shields","year":"2014","unstructured":"Shields RK, Nguyen MH, Press EG, Clancy CJ. Abdominal candidiasis is a hidden reservoir of echinocandin resistance. Antimicrob Agents Chemother. 2014;58(12):7601\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1640_CR194","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1469-0691.2010.03360.x","volume":"17","author":"P Montravers","year":"2011","unstructured":"Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O, AmarCand study group. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect. 2011;17(7):1061\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1640_CR195","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/01.CCM.0000201889.39443.D2","volume":"34","author":"P Montravers","year":"2006","unstructured":"Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006;34(3):646\u201352.","journal-title":"Crit Care Med"},{"issue":"8677","key":"1640_CR196","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0140-6736(89)92043-6","volume":"2","author":"T Calandra","year":"1989","unstructured":"Calandra T, Bille J, Schneider R, Mosimann F, Francioli P. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet. 1989;2(8677):1437\u201340.","journal-title":"Lancet"},{"issue":"2","key":"1640_CR197","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MCC.0b013e328028fd92","volume":"13","author":"SI Blot","year":"2007","unstructured":"Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care. 2007;13(2):195\u20139.","journal-title":"Curr Opin Crit Care"},{"issue":"12","key":"1640_CR198","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1007\/s00268-011-1305-2","volume":"35","author":"HA Carneiro","year":"2011","unstructured":"Carneiro HA, Mavrakis A, Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg. 2011;35(12):2650\u20139.","journal-title":"World J Surg"},{"issue":"3","key":"1640_CR199","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","volume":"40","author":"E Azoulay","year":"2012","unstructured":"Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, et al. Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med. 2012;40(3):813\u201322.","journal-title":"Crit Care Med"},{"issue":"12","key":"1640_CR200","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/cid\/cit140","volume":"56","author":"L Ostrosky-Zeichner","year":"2013","unstructured":"Ostrosky-Zeichner L. Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida. Clin Infect Dis. 2013;56(12):1733\u20134.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1640_CR201","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"1640_CR202","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"1640_CR203","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/myc.12330","volume":"58","author":"M Sanguinetti","year":"2015","unstructured":"Sanguinetti M, Posteraro B, Lass-Fl\u00f6rl C. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses. 2015;58(Suppl 2):2\u201313.","journal-title":"Mycoses"},{"issue":"1 Suppl","key":"1640_CR204","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125(1 Suppl):S3-13.","journal-title":"Am J Med"},{"issue":"6","key":"1640_CR205","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","volume":"27","author":"MC Arendrup","year":"2014","unstructured":"Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis. 2014;27(6):484\u201392.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"1640_CR206","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1128\/AAC.01763-15","volume":"60","author":"RH Jensen","year":"2015","unstructured":"Jensen RH, Johansen HK, S\u00f8es LM, Lemming LE, Rosenvinge FS, Nielsen L, et al. posttreatment antifungal resistance among colonizing candida isolates in candidemia patients: results from a systematic multicenter study. Antimicrob Agents Chemother. 2015;60(3):1500\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1640_CR207","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00134-018-5363-x","volume":"45","author":"A Cortegiani","year":"2019","unstructured":"Cortegiani A, Misseri G, Chowdhary A. What\u2019s new on emerging resistant Candida species. Intensive Care Med. 2019;45(4):512\u20135.","journal-title":"Intensive Care Med"},{"issue":"9","key":"1640_CR208","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00134-014-3404-7","volume":"40","author":"D Maubon","year":"2014","unstructured":"Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 2014;40(9):1241\u201355.","journal-title":"Intensive Care Med"},{"issue":"7","key":"1640_CR209","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/1469-0691.12440","volume":"20","author":"C Orasch","year":"2014","unstructured":"Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, M\u00fchlethaler K, et al. Candida species distribution and antifungal susceptibility testing according to European committee on antimicrobial susceptibility testing and new vs. old clinical and laboratory standards institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Clin Microbiol Infect. 2014;20(7):698\u2013705.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1640_CR210","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2217\/fmb-2018-0059","volume":"13","author":"J Beardsley","year":"2018","unstructured":"Beardsley J, Halliday CL, Chen SC, Sorrell TC. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside. Future Microbiol. 2018;13(10):1175\u201391.","journal-title":"Future Microbiol"},{"issue":"8","key":"1640_CR211","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1128\/AAC.00479-10","volume":"54","author":"J Garnacho-Montero","year":"2010","unstructured":"Garnacho-Montero J, D\u00edaz-Mart\u00edn A, Garc\u00eda-Cabrera E, P\u00e9rez R, de Pipa\u00f3n M, Hern\u00e1ndez-Caballero C, Aznar-Mart\u00edn J, et al. Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother. 2010;54(8):3149\u201354.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1640_CR212","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","volume":"85","author":"M Castanheira","year":"2016","unstructured":"Castanheira M, Messer SA, Rhomberg PR, Pfaller MA. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY antifungal surveillance program (2013). Diagn Microbiol Infect Dis. 2016;85(2):200\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"1640_CR213","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1086\/500939","volume":"42","author":"M Krogh-Madsen","year":"2006","unstructured":"Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis. 2006;42(7):938\u201344.","journal-title":"Clin Infect Dis"},{"issue":"9312","key":"1640_CR214","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","volume":"359","author":"DP Kontoyiannis","year":"2002","unstructured":"Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet. 2002;359(9312):1135\u201344.","journal-title":"Lancet"},{"issue":"2","key":"1640_CR215","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","volume":"36","author":"S Silva","year":"2012","unstructured":"Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288\u2013305.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"1640_CR216","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ofid\/ofv163","volume":"2","author":"S Vallabhaneni","year":"2015","unstructured":"Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG, et al. Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014. Open Forum Infect Dis. 2015;2(4):163.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"1640_CR217","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol. 2013;51(8):2571\u201381.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1640_CR218","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1128\/AAC.03255-14","volume":"58","author":"CD Pham","year":"2014","unstructured":"Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, et al. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Antimicrob Agents Chemother. 2014;58(8):4690\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1640_CR219","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3201\/eid2011.140685","volume":"20","author":"D Farmakiotis","year":"2014","unstructured":"Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis. 2014;20(11):1833\u201340.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1640_CR220","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1128\/JCM.06112-11","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol. 2012;50(4):1199\u2013203.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1640_CR221","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011. Clin Infect Dis. 2012;55(10):1352\u201361.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1640_CR222","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/jac\/dkv445","volume":"71","author":"A Ko\u0142aczkowska","year":"2016","unstructured":"Ko\u0142aczkowska A, Ko\u0142aczkowski M. Drug resistance mechanisms and their regulation in non-albicans Candida species. J Antimicrob Chemother. 2016;71(6):1438\u201350.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"1640_CR223","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1128\/AAC.01973-15","volume":"59","author":"RK Shields","year":"2015","unstructured":"Shields RK, Nguyen MH, Press EG, Cumbie R, Driscoll E, Pasculle AW, et al. Rate of fks mutations among consecutive Candida isolates causing bloodstream infection. Antimicrob Agents Chemother. 2015;59(12):7465\u201370.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1640_CR224","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/cid\/ciu407","volume":"59","author":"ND Beyda","year":"2014","unstructured":"Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014;59(6):819\u201325.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1640_CR225","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s15010-020-01475-8","volume":"48","author":"AT Coste","year":"2020","unstructured":"Coste AT, Kritikos A, Li J, Khanna N, Goldenberger D, Garzoni C, et al. Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland. Infection. 2020;48(5):761\u20136.","journal-title":"Infection"},{"issue":"8","key":"1640_CR226","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/AAC.00136-13","volume":"57","author":"RK Shields","year":"2013","unstructured":"Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Antimicrob Agents Chemother. 2013;57(8):3528\u201335.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1640_CR227","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","volume":"61","author":"DS Perlin","year":"2015","unstructured":"Perlin DS. Echinocandin resistance in Candida. Clin Infect Dis. 2015;61(6):S612\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1640_CR228","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1093\/infdis\/jix131","volume":"216","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(3):S445\u201351.","journal-title":"J Infect Dis"},{"issue":"1","key":"1640_CR229","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis. 2008;46(1):120\u20138.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1640_CR230","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134\u201340.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1640_CR231","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/JCM.00367-15","volume":"53","author":"S Kathuria","year":"2015","unstructured":"Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant candida auris misidentified as candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by vitek 2, CLSI broth microdilution, and etest method. J Clin Microbiol. 2015;53(6):1823\u201330.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1640_CR232","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1128\/JCM.01787-16","volume":"55","author":"EA Idelevich","year":"2016","unstructured":"Idelevich EA, Gr\u00fcnastel B, Becker K. Rapid detection and identification of candidemia by direct blood culturing on solid medium by use of lysis-centrifugation method combined with matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). J Clin Microbiol. 2016;55(1):97\u2013100.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1640_CR233","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/myc.12746","volume":"61","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Fl\u00f6rl C, et al. EQUAL Candida score: an ECMM score derived from current guidelines to measure quality of clinical candidaemia management. Mycoses. 2018;61(5):326\u201330.","journal-title":"Mycoses"},{"issue":"3","key":"1640_CR234","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","volume":"222","author":"MD Johnson","year":"2020","unstructured":"Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, et al. Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020;222(3):S175\u201398.","journal-title":"J Infect Dis"},{"issue":"2","key":"1640_CR235","doi-asserted-by":"publisher","first-page":"ii5","DOI":"10.1093\/jac\/dkw391","volume":"71","author":"P Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz P, Bouza E, COMIC (Collaboration Group on Mycosis) study group. The current treatment landscape: the need for antifungal stewardship programmes. J Antimicrob Chemother. 2016;71(2):ii5\u201312.","journal-title":"J Antimicrob Chemother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-021-01640-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T05:24:51Z","timestamp":1650259491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-021-01640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":235,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1007\/s15010-021-01640-7","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"21 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}